首页> 外文期刊>The American journal on addictions / >Treatment compliance in patients with comorbid psychiatric and substance use disorders.
【24h】

Treatment compliance in patients with comorbid psychiatric and substance use disorders.

机译:合并精神病和药物滥用疾病的患者的治疗依从性。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

This study examines clinical and non-clinical factors associated with treatment compliance problems in 342 patients with substance use disorders (SUD) seen in routine psychiatric practice. Weighted Wald-X(2) and multivariate logistic regression assessed sociodemographic, clinical, treatment, and health plan characteristics associated with treatment compliance problems. Among patients with SUD, 40.5% were reported to currently have treatment compliance problems. Patients with treatment compliance problems were significantly more likely to have personality disorders, lower global assessment of functioning scores, and medication side effects than those without treatment compliance problems. Patients seen by psychiatrists who were reimbursed by discounted rather than undiscounted fee-for-service were five times more likely to be reported to have treatment compliance problems. Both clinical and non-clinical factors appear to be associated with treatment compliance problems. Understanding these factors and targeting treatment interventions may improve treatment compliance and patient outcomes.
机译:这项研究检查了常规精神病学实践中发现的342名药物滥用障碍(SUD)患者中与治疗依从性问题相关的临床和非临床因素。加权Wald-X(2)和多元Logistic回归评估与治疗依从性问题相关的社会人口统计学,临床,治疗和健康计划特征。在SUD患者中,据报道40.5%的患者目前存在治疗依从性问题。有治疗依从性问题的患者比没有治疗依从性问题的患者更有可能出现人格障碍,功能评分总体评估较低和药物副作用。由精神科医生看过的患者,通过打折而不是未折现的服务费获得报销,他们被报告患有治疗依从性问题的可能性要高五倍。临床和非临床因素似乎都与治疗依从性问题有关。了解这些因素并针对治疗干预措施可以改善治疗依从性和患者预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号